TDP-43 in the Aging Brain: When and Where?

TDP-43 in the Aging Brain: When and Where? is sponsored by BrightFocus Foundation. Examines the role of TDP-43 protein aggregates in accelerating cognitive decline in Alzheimer's patients.

TDP-43 in the Aging Brain: When and Where? Grants > TDP-43 in the Aging Brain: When and Where? Alzheimer's Disease Research Grant TDP-43 in the Aging Brain: When and Where?

Icahn School of Medicine at Mount Sinai Alzheimer's Disease Research July 01, 2025 - June 30, 2028 Co-Principal Investigator(s) Kurt Farrell, PhD, Icahn School of Medicine at Mount Sinai The presence of TDP-43 protein aggregates is linked to a faster decline in Alzheimer’s patients. We will assess a large collection of human brains for TDP-43 and isolate the most affected cells.

Diseases of the aging brain, such as Alzheimer’s, are caused by multiple factors, including the proteins amyloid and tau, but recently, an additional protein, TDP-43, has been linked to a faster decline in some patients. We will investigate TDP-43 in a set of autopsied brains from multiple diseases and associate its presence with the presence of amyloid and tau.

We will then study which specific brain cells contain changes in TDP-43 levels and what that does to them, which could help to understand how TDP-43 relates to aging and dementia. Our proposal applies state-of-the-art computer vision and machine learning techniques to more accurately characterize the burden of TDP-43 pathology in the aging and Alzheimer’s brain.

Secondly, the cell types and subtypes most affected by TDP-43 pathology are unknown. For the first time we will identify TDP-43 pathology-burdened cells by their gene profiles. Personalized medicine for neurodegeneration aims to identify specific subtypes of disease to develop targeted therapies, analogous to the rapid progress in the cancer field.

By dissecting the contribution of TDP-43 to Alzheimer’s and aging, we are laying the groundwork for molecularly targeted therapies.

Alzheimer's Disease Research Evaluating the Role of the TDP-43 Protein in Alzheimer's Disease Pathogenesis July 01, 2024 - June 30, 2027 Alzheimer's Disease Research Decoding the Role of an Alzheimer's Causal Gene in Distinct Brain Cell Types July 01, 2024 - June 30, 2027 Flemish Institute for Biotechnology Alzheimer's Disease Research Nuclear Material Transfer in Pathogenic Protein Spreading July 01, 2023 - June 30, 2026 Shriners Hospitals for Children